NCT06799169View on ClinicalTrials.gov

Management of Acute Tinnitus With Migraine Medications

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Tinnitus
Interventions
DRUG

Nortriptyline

Nortriptyline (7.5 mg) plus Topiramate (10 mg) taken by mouth daily with appropriate dosage increase as necessary

DRUG

Topiramate

Nortriptyline (7.5 mg) plus Topiramate (10 mg) taken by mouth daily with appropriate dosage increase as necessary

DRUG

Paroxetine

Verapamil (30 mg) plus Paroxetine (4 mg) taken by mouth daily with appropriate dosage increase as necessary

DRUG

Verapamil

Verapamil (30 mg) plus Paroxetine (4 mg) taken by mouth daily with appropriate dosage increase as necessary

Trial Locations (1)

92868

University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT06799169 - Management of Acute Tinnitus With Migraine Medications | Biotech Hunter | Biotech Hunter